UPPALURI SUBBARAO V 4

What Happened

• Uppaluri Subbarao V, a director of OPKO Health, was granted derivative awards on June 18, 2026 for a total of 80,000 shares. The Form 4 reports the acquisition as 80,000 shares at $0.00 (a grant/award of options), i.e., this was a compensation grant, not an open-market purchase or sale.

Key Details

• Transaction date: 2026-06-18; filing date: 2026-06-22 (filed within standard Form 4 timing).
• Reported as an "A" (award/grant) of 80,000 shares at $0.00 (derivative instrument — option grant).
• Footnote: Issuer canceled a prior 50,000‑option grant to the reporting person, granted a new option for 30,000 shares and reissued an option for 50,000 shares (total 80,000 options) as part of standard director compensation.
• Shares owned after the transaction: not specified in the provided filing.

Context

• This filing reflects option grants (rights to buy common stock in the future), not an exercise or sale of shares; no immediate cashless sale or proceeds were reported.
• Option grants to directors are common as routine compensation and do not, by themselves, necessarily signal a change in the director’s market view.